Clinical Trial Update: Effect of Vivomixx® on Neuroinflammation in Patients Withs Cirrhosis [NA]

View source ↗

Summary

The clinical trial evaluating Vivomixx for neuroinflammation in patients with cirrhosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis

Drugs mentioned

• Vivomixx (Probiotic formulation)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Cirrhosis, Liver | NA | Status: WITHDRAWN